{"id":20031,"date":"2004-01-23T12:51:17","date_gmt":"2004-01-23T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=20031"},"modified":"2018-04-11T05:56:31","modified_gmt":"2018-04-11T10:56:31","slug":"20031","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/20031\/","title":{"rendered":"2004 \u5e74 1 \u6708 23 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN-1-23-04.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>*******************************************************************<br \/>\n&nbsp;<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n&nbsp;2004 \u5e74 1 \u6708 23 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<br \/>\n<\/strong>&nbsp;\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n*******************************************************************<br \/>\n\u60a8\u73b0\u5728\u53ef\u4ee5\u4f7f\u7528\u6b64\u90e8\u5206\u76f4\u63a5\u8df3\u8f6c\u5230\u6709\u5173\u7279\u5b9a\u516c\u53f8\u7684\u65b0\u95fb\u3002\u53ea\u9700\u5355\u51fb\u516c\u53f8\u540d\u79f0\u5373\u53ef\u3002 <br \/>\n&nbsp;<br \/>\n\u7acb\u5373\u6ce8\u518c\u4ee5\u9884\u8ba2 2004 \u5e74 2 \u6708\u897f\u90e8\u517d\u533b\u5927\u4f1a\u6982\u89c8\u7684\u5e2d\u4f4d<br \/>\n&nbsp;<br \/>\n\u8df3\u81f3\uff1a<br \/>\n&nbsp;<br \/>\n<u>\u6536\u76ca<\/u>:<br \/>\n\u9053\u5947\u5821<br \/>\n\u8bfa\u534e<br \/>\n\u8f89\u745e<br \/>\n\u7ef4\u514b\u516c\u53f8<br \/>\n&nbsp;<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<\/u>:<br \/>\n\u96c5\u57f9\u5b9e\u9a8c\u5ba4<br \/>\n\u52c3\u6797\u683c\u6bb7\u683c\u7ff0<br \/>\n\u6069\u8d39\u5c14\u79d1\u5b66<br \/>\n\u6613\u5408\u4e92\u52a8<br \/>\n\u6cd5\u7eb3\u59c6<br \/>\n\u8d6b\u65af\u5361<br \/>\n\u82f1\u7279\u5a01<br \/>\n\u5362\u4f0a\u7279\u6ce2\u5c14\u5fb7<br \/>\n\u6885\u91cc\u4e9a\u5c14<br \/>\n\u8bfa\u534e<br \/>\n\u5ba0\u7269\u533b\u7597\u5feb\u9012<br \/>\n\u533b\u836f\u5dee\u8ddd<br \/>\n\u666e\u62c9\u59c6\u7f57\u65af\u7f8e\u56fd<br \/>\n\u7ef4\u514b\u516c\u53f8<br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; \u8f89\u745e\u516c\u53f8\u516c\u5e03\u4e86\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8 2003 \u5e74\u7b2c\u56db\u5b63\u5ea6\u548c\u5e74\u672b\u7684\u4e1a\u7ee9\u3002\u5e74\u672b\u6536\u5165\u4e3a $15.98 \u4ebf\u7f8e\u5143\uff0c\u6bd4 2002 \u5e74\u589e\u957f 43%\uff0c\u8fd9\u53cd\u6620\u4e86 2003 \u5e74\u6536\u8d2d Pharmacia \u7684\u5f71\u54cd\u3002\u7b2c\u56db\u5b63\u5ea6\u6536\u5165\u4e3a $5.08 \u4ebf\u7f8e\u5143\uff0c\u589e\u957f 57%\u3002\u7b2c\u56db\u5b63\u5ea6\u4e1a\u7ee9\u53cd\u6620\u4e86 Pharmacia \u4ea7\u54c1\u7ec4\u5408\u7684\u589e\u52a0\uff0c\u5e76\u53d7\u5230\u4f34\u4fa3\u52a8\u7269\u4ea7\u54c1 Rimadyl\u3001Revolution \u548c Clavamox\/Synulox \u4ee5\u53ca\u725b\u751f\u7269\u5236\u54c1\u7684\u5f3a\u52b2\u8868\u73b0\u4ee5\u53ca\u6709\u5229\u7684\u8d27\u5e01\u6c47\u7387\u7684\u63a8\u52a8\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; \u8bfa\u534e\u516c\u5e03\u4e86\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8 2003 \u5e74\u7b2c\u56db\u5b63\u5ea6\u548c\u5e74\u672b\u7684\u4e1a\u7ee9\u3002\u5168\u5e74\u9500\u552e\u989d\u4e3a $6.82 \u4ebf\uff0c\u6bd4 2002 \u5e74\u589e\u957f 9%\uff0c\u8fd9\u5f97\u76ca\u4e8e\u4f34\u4fa3\u52a8\u7269\u7279\u8bb8\u7ecf\u8425\u7684\u4e24\u4f4d\u6570\u589e\u957f\uff0c\u518d\u52a0\u4e0a\u521b\u65b0\u7684\u519c\u573a\u82cd\u8747\u63a7\u5236\u4ea7\u54c1 Agita \u7684\u8d21\u732e\uff0c\u62b5\u6d88\u4e86\u6cbb\u7597\u6027\u6297\u611f\u67d3\u4e1a\u52a1\u4e0d\u5229\u6761\u4ef6\u7684\u5f71\u54cd\u3002\u7b2c\u56db\u5b63\u5ea6\u9500\u552e\u989d\u4e3a $1.8 \u4ebf\uff0c\u6bd4 2002 \u5e74\u7b2c\u56db\u5b63\u5ea6\u589e\u957f 18%\u3002\u8be5\u90e8\u95e8\u5728\u7b2c\u56db\u5b63\u5ea6\u83b7\u5f97\u4e86\u6740\u866b\u5242\u7279\u8bb8\u7ecf\u8425\u6743\u7684\u63d0\u632f\uff0c\u5c24\u5176\u662f\u65b0\u63a8\u51fa\u7684\u72d7\u5173\u8282\u708e\u6cbb\u7597\u836f\u7269 Deramaxx\uff0c\u8be5\u836f\u7269\u5b9e\u73b0\u4e86\u5f3a\u52b2\u7684\u7ec6\u5206\u5e02\u573a\u4efd\u989d\u589e\u957f\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; \u60e0\u6c0f\u5ba3\u5e03\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8 Fort Dodge Animal Health 2003 \u5e74\u7b2c\u56db\u5b63\u5ea6\u548c\u5e74\u7ec8\u4e1a\u7ee9\u3002\u7b2c\u56db\u5b63\u5ea6\u6536\u5165\u4e3a $1.88 \u4ebf\u7f8e\u5143\uff0c\u4e0e 2002 \u5e74\u7b2c\u56db\u5b63\u5ea6\u76f8\u6bd4\u589e\u957f\u4e86 11%\u3002\u5168\u5e74\u6536\u5165\u4e3a $7.93 \u4ebf\u7f8e\u5143\uff0c\u4e0e 2002 \u5e74\u76f8\u6bd4\u589e\u957f\u4e86 21%\u3002\u6536\u5165\u589e\u957f\u7684\u4e3b\u8981\u539f\u56e0\u662f ProHeart 6 \u5728\u7f8e\u56fd\u7684\u9500\u91cf\u4e0e\u53bb\u5e74\u540c\u671f\u76f8\u6bd4\u6709\u6240\u589e\u52a0\uff0c\u8fd9\u53d7\u5230\u4e86 ProHeart 6 \u4ea7\u54c1\u5927\u91cf\u9000\u8d27\u7684\u5f71\u54cd\u3002\u8be5\u516c\u53f8\u7684 West Nile Innovator \u9a6c\u75ab\u82d7\u5728\u7f8e\u56fd\u7684\u9500\u552e\u4e5f\u5bf9\u5168\u5e74\u4e1a\u7ee9\u4ea7\u751f\u4e86\u79ef\u6781\u5f71\u54cd\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Virbac SA \u516c\u5e03\u4e86 2003 \u5e74\u7684\u521d\u6b65\u4e1a\u7ee9\u3002\u96c6\u56e2\u6536\u5165\u4e3a 3.54 \u4ebf\u6b27\u5143\uff08$4.45 \u4ebf\uff09\uff0c\u4e0e 2002 \u5e74\u76f8\u6bd4\u4e0b\u964d\u4e86 4%\u3002\u6392\u9664\u6c47\u7387\u5f71\u54cd\uff0c\u6536\u5165\u589e\u957f\u4e86 2.4%\u3002\u4e0d\u5305\u62ec\u7f8e\u56fd\uff08Virbac Corp.\uff09\u7684\u96c6\u56e2\u6536\u5165\u4e3a 2.98 \u4ebf\u6b27\u5143\uff08$3.75 \u4ebf\uff09\uff0c\u4e0b\u964d\u4e86 1%\u3002\u4e0e 2002 \u5e74\u76f8\u6bd4\uff0cVirbac Corp. \u7684\u6536\u5165\u4e0b\u964d\u4e86 16%\u3002\u7f8e\u56fd\u5b50\u516c\u53f8\u8d21\u732e\u7684\u5927\u5e45\u4e0b\u964d\u662f\u7531\u4e8e (1) \u7f8e\u5143\u5bf9\u6b27\u5143\u8d2c\u503c\uff1b(2) \u5e74\u672b\u8c28\u614e\u7684\u4fc3\u9500\u653f\u7b56\uff1b\u4ee5\u53ca (3) Virbac Corp \u5ba1\u8ba1\u59d4\u5458\u4f1a\u6700\u8fd1\u7684\u8c03\u67e5\u5bfc\u81f4 2003 \u5e74\u91c7\u7528\u4e86\u4e0d\u540c\u7684\u9500\u552e\u786e\u8ba4\u4f1a\u8ba1\u65b9\u6cd5\u3002\u7531\u4e8e\u7f8e\u56fd\u548c\u6cd5\u56fd\u516c\u8ba4\u4f1a\u8ba1\u539f\u5219\u4e4b\u95f4\u7684\u5dee\u5f02\uff0c\u7ef4\u514b\u516c\u53f8 (Virbac Corp.) \u7684\u521d\u6b65\u4e1a\u7ee9\u5c06\u4e0e\u7ef4\u514b\u516c\u53f8 (Virbac Corp.) \u5355\u72ec\u53d1\u5e03\u7684\u4e1a\u7ee9\u6709\u6240\u4e0d\u540c\u3002 (Business Wire) \u9876\u90e8<br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; Luitpold Pharmaceuticals \u548c Novartis \u5ba3\u5e03\u8fbe\u6210\u534f\u8bae\uff0c\u6388\u4e88 Novartis \u5728\u7f8e\u56fd\u8425\u9500\u3001\u9500\u552e\u548c\u652f\u6301 Luitpold \u7684 Adequan Canine \u7684\u6743\u5229\u3002Adequan Canine \u5df2\u88ab FDA \u5f52\u7c7b\u4e3a\u6539\u5584\u75c5\u60c5\u7684\u9aa8\u5173\u8282\u708e\u836f\u7269\uff0c\u636e\u8be5\u516c\u53f8\u79f0\uff0c\u8fd9\u662f\u8be5\u7c7b\u522b\u4e2d\u552f\u4e00\u7684\u6b64\u7c7b\u836f\u7269\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Merial \u548c Boehringer Ingelheim Vetmedica \u5ba3\u5e03\uff0cFDA \u5df2\u6279\u51c6 Metacam \u6ce8\u5c04\u5242\u7684\u4e0a\u5e02\uff0c\u8fd9\u662f\u4e00\u79cd\u975e\u753e\u4f53\u6297\u708e\u836f (NSAID)\u3002\u4e0e 2003 \u5e74\u83b7\u6279\u7684 Metacam \u53e3\u670d\u6df7\u60ac\u6db2\u76f8\u7ed3\u5408\uff0c\u8be5\u6ce8\u5c04\u5242\u4e3a\u517d\u533b\u53ca\u5176\u5ba2\u6237\u63d0\u4f9b\u4e86\u7ecf\u8fc7\u9a8c\u8bc1\u7684\u6709\u6548\u7cfb\u7edf\uff0c\u53ef\u7f13\u89e3\u72ac\u9aa8\u5173\u8282\u708e (OA) \u5f15\u8d77\u7684\u75bc\u75db\u548c\u708e\u75c7\u3002Metacam \u6ce8\u5c04\u5242\u5df2\u5728\u52a0\u62ff\u5927\u548c\u6b27\u6d32\u6210\u529f\u4f7f\u7528\u591a\u5e74\u3002\u8be5\u4ea7\u54c1\u83b7\u51c6\u7528\u4e8e\u76ae\u4e0b\u548c\u9759\u8109\u6ce8\u5c04\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; \u96c5\u57f9\u5b9e\u9a8c\u5ba4\u4e3a\u5176 BSE \u68c0\u6d4b\u63d0\u4ea4\u4e86\u4e00\u4efd\u517d\u533b\u751f\u7269\u4ea7\u54c1\u8bb8\u53ef\u7533\u8bf7\uff0c\u8be5\u7533\u8bf7\u6b63\u5728\u7b49\u5f85\u7f8e\u56fd\u519c\u4e1a\u90e8\u7684\u5ba1\u67e5\u3002\u96c5\u57f9\u6b64\u524d\u4e8e 2003 \u5e74 10 \u6708\u5411\u7f8e\u56fd\u519c\u4e1a\u90e8\u63d0\u4ea4\u4e86 BSE \u68c0\u6d4b\u6570\u636e\u3002\u6b64\u5916\uff0c\u7f8e\u56fd\u519c\u4e1a\u90e8\u8fd8\u68c0\u67e5\u4e86\u8be5\u68c0\u6d4b\u5728\u7231\u5c14\u5170\u7684\u751f\u4ea7\u57fa\u5730\u548c\u96c5\u57f9\u5728\u7f8e\u56fd\u7684\u5206\u9500\u4e2d\u5fc3\u3002\u81ea 2001 \u5e74\u4e0e\u7231\u5c14\u5170\u7684 Enfer Scientific Ltd. \u7b7e\u8ba2\u8425\u9500\u548c\u5206\u9500\u534f\u8bae\u4ee5\u6765\uff0c\u96c5\u57f9\u4e00\u76f4\u5728\u7f8e\u56fd\u5883\u5916\u9500\u552e\u8be5\u68c0\u6d4b\uff0c\u5e76\u62e5\u6709\u5728\u7231\u5c14\u5170\u4ee5\u5916\u5730\u533a\u9500\u552e\u8be5\u68c0\u6d4b\u7684\u72ec\u5bb6\u6743\u5229\u3002Enfer BSE \u68c0\u6d4b\u5df2\u83b7\u5f97\u6b27\u76df\u548c\u65e5\u672c\u7684\u6279\u51c6\uff0c\u53ef\u7528\u4e8e\u725b\u68c0\u6d4b\u3002\u76ee\u524d\u7f8e\u56fd\u519c\u4e1a\u90e8\u6279\u51c6\u7684\u552f\u4e00 BSE \u68c0\u6d4b\u662f\u514d\u75ab\u7ec4\u7ec7\u5316\u5b66\u68c0\u6d4b\uff0c\u9700\u8981\u51e0\u5929\u65f6\u95f4\u624d\u80fd\u5f97\u5230\u7ed3\u679c\u3002\u5feb\u901f Enfer BSE \u68c0\u6d4b\u65e8\u5728\u5728\u6570\u5c0f\u65f6\u5185\u4ea7\u751f\u7ed3\u679c\u3002\uff08Meating Place\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Heska Corp. \u5ba3\u5e03\u63a8\u51fa Heska CBC-Diff \u517d\u533b\u8840\u6db2\u5b66\u7cfb\u7edf\u3002\u65b0\u7684 CBC-Diff \u7cfb\u7edf\u53ef\u5728\u4e0d\u5230\u4e00\u5206\u949f\u7684\u65f6\u95f4\u5185\u4ee5\u7ecf\u6d4e\u9ad8\u6548\u7684\u65b9\u5f0f\u63d0\u4f9b\u53ef\u9760\u7684\u7ed3\u679c\u3002\u5b83\u8fd8\u5177\u6709 True-20 \u91c7\u6837\u529f\u80fd\uff0c\u53ea\u9700\u62bd\u53d6 20 \u5fae\u5347\u8840\u6db2\u5373\u53ef\u83b7\u5f97\u51c6\u786e\u7684\u7ed3\u679c\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Intervet \u548c PharmaGap Inc. \u5ba3\u5e03\u7b7e\u7f72\u5408\u4f5c\u7814\u7a76\u534f\u8bae\uff0c\u4ee5 PharmaGap \u4e13\u6709\u7684\u7ec6\u80de\u68c0\u6d4b\u5e73\u53f0\u4e3a\u57fa\u7840\uff0c\u8bbe\u8ba1\u548c\u5f00\u53d1\u4e00\u79cd\u5316\u5408\u7269\u7b5b\u9009\u68c0\u6d4b\u65b9\u6cd5\uff0c\u7528\u4e8e\u4e3a\u519c\u573a\u52a8\u7269\u548c\u4f34\u4fa3\u52a8\u7269\u4ee5\u53ca\u5176\u4ed6\u5e94\u7528\u9009\u62e9\u5019\u9009\u836f\u7269\u3002Intervet \u5c06\u4fdd\u7559\u4f7f\u7528 PharmaGap \u68c0\u6d4b\u6280\u672f\u7b5b\u9009\u52a8\u7269\u5e02\u573a\u5316\u5408\u7269\u7684\u5168\u7403\u72ec\u5bb6\u6743\u5229\u3002\u4f5c\u4e3a\u534f\u8bae\u7684\u4e00\u90e8\u5206\uff0cIntervet \u5c06\u5411 PharmaGap \u652f\u4ed8\u9884\u4ed8\u6b3e\u548c\u540e\u7eed\u91cc\u7a0b\u7891\u4ed8\u6b3e\u3002\u5177\u4f53\u7ec6\u8282\u672a\u62ab\u9732\u3002\uff08\u9972\u6599\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Virbac Corp. \u6536\u5230\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u5e02\u573a\u7684\u901a\u77e5\uff0c\u7eb3\u65af\u8fbe\u514b\u4e0a\u5e02\u8d44\u683c\u5ba1\u67e5\u5c0f\u7ec4\u5df2\u51b3\u5b9a\u4ece 2004 \u5e74 1 \u6708 23 \u65e5\u5f00\u5e02\u8d77\uff0c\u5c06\u8be5\u516c\u53f8\u666e\u901a\u80a1\u4ece\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u5e02\u573a\u9664\u540d\u3002\u8be5\u516c\u53f8\u56e0\u672a\u80fd\u63d0\u4ea4\u622a\u81f3 2003 \u5e74 9 \u6708 30 \u65e5\u7684 10-Q \u8868\u5b63\u5ea6\u62a5\u544a\u800c\u672a\u80fd\u9075\u5b88\u5e02\u573a\u89c4\u5219 4310(c)(14)\uff0c\u56e0\u6b64\u88ab\u9664\u540d\u3002\u5c3d\u7ba1\u8be5\u516c\u53f8\u6253\u7b97\u5411\u7eb3\u65af\u8fbe\u514b\u4e0a\u5e02\u548c\u542c\u8bc1\u5ba1\u67e5\u59d4\u5458\u4f1a\u4e0a\u8bc9\uff0c\u4f46\u4e0a\u8bc9\u4e0d\u4f1a\u963b\u6b62\u9664\u540d\u3002\u7531\u4e8e\u8be5\u516c\u53f8\u7684\u5b9a\u671f\u62a5\u544a\u4e0d\u662f\u6700\u65b0\u7684\uff0c\u5176\u666e\u901a\u80a1\u4e5f\u4e0d\u4f1a\u7acb\u5373\u6709\u8d44\u683c\u5728 OTC \u516c\u544a\u677f\u4e0a\u4ea4\u6613\u3002\uff08Business Wire\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Farnam Horse Products \u5ba3\u5e03\u63a8\u51fa\u4e00\u6b3e\u65b0\u578b\u5e7f\u8c31\u9a6c\u7528\u9a71\u866b\u5242\u3002ComboCare \u5c06\u83ab\u897f\u514b\u4e01\u4e0e\u5421\u55b9\u916e\u76f8\u7ed3\u5408\uff0c\u53ef\u6740\u6b7b\u86d4\u866b\u3001\u7ee6\u866b\u3001\u5c0f\u578b\u5706\u7ebf\u866b\uff08\u5305\u62ec\u5305\u56ca\u9636\u6bb5\uff09\u548c\u9a6c\u80c3\u8747\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; PetMed Express, Inc. \u5ba3\u5e03\u5176\u5728\u7eb3\u65af\u8fbe\u514b\u5168\u56fd\u5e02\u573a\u4e0a\u5e02\u7684\u7533\u8bf7\u5df2\u83b7\u6279\u51c6\uff0c\u8be5\u516c\u53f8\u9884\u8ba1\u5c06\u4e8e 2004 \u5e74 1 \u6708 23 \u65e5\u661f\u671f\u4e94\u5728\u5168\u56fd\u5e02\u573a\u4ee5\u201cPETS\u201d\u4ee3\u7801\u8fdb\u884c\u4ea4\u6613\u3002\u5728\u5373\u5c06\u8f6c\u5165\u7eb3\u65af\u8fbe\u514b\u5168\u56fd\u5e02\u573a\u4e4b\u524d\uff0cPetMed Express \u80a1\u7968\u5728\u573a\u5916\u4ea4\u6613\u516c\u544a\u677f\u4e0a\u4ea4\u6613\u3002\uff08Business Wire\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; eMerge Interactive \u5ba3\u5e03\u5df2\u4e0e\u673a\u6784\u6295\u8d44\u8005\u8fbe\u6210\u534f\u8bae\uff0c\u79c1\u52df\u666e\u901a\u80a1\u548c\u8ba4\u80a1\u6743\u8bc1\uff0c\u7b79\u96c6 $7 \u767e\u4e07\u6536\u76ca\u3002\u8fd9\u4e9b\u6536\u76ca\u52a0\u4e0a Excel Corp. \u7684\u52a0\u901f\u79df\u8d41\u4ed8\u6b3e\u5c06\u4e3a\u516c\u53f8\u63d0\u4f9b\u8d85\u8fc7 $10 \u767e\u4e07\u7684\u8425\u8fd0\u8d44\u91d1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n&gt; Plumrose USA \u662f\u7f8e\u56fd\u6700\u5927\u7684\u4f18\u8d28\u5207\u7247\u8089\u548c\u719f\u98df\u706b\u817f\u751f\u4ea7\u5546\u4e4b\u4e00\uff0c\u8be5\u516c\u53f8\u5df2\u5728\u5176\u4f4d\u4e8e\u5bc6\u897f\u897f\u6bd4\u5dde\u5e03\u6069\u7ef4\u5c14\u7684\u5de5\u5382\u91c7\u7528\u4e86\u4e00\u79cd\u65b0\u7684\u98df\u54c1\u75c5\u539f\u4f53\u68c0\u6d4b\u7cfb\u7edf Genevision\u3002Genevision \u4f7f\u7528\u5148\u8fdb\u7684 DNA \u68c0\u6d4b\u6280\u672f\uff0c\u53ef\u5728\u4e0d\u5230 24 \u5c0f\u65f6\u5185\u5feb\u901f\u8f7b\u677e\u5730\u786e\u5b9a\u7ed9\u5b9a\u98df\u54c1\u6837\u672c\u7684\u5b89\u5168\u6027\uff0c\u8fd9\u6bd4\u9700\u8981\u4e94\u5230\u4e03\u5929\u7684\u4f20\u7edf\u5fae\u751f\u7269\u5b66\u6d4b\u8bd5\u6709\u4e86\u663e\u8457\u7684\u6539\u8fdb\u3002\u8fd9\u79cd\u7f29\u77ed\u7684\u7ed3\u679c\u83b7\u53d6\u65f6\u95f4\u5c06\u589e\u5f3a Plumrose \u7684\u8d28\u91cf\u63a7\u5236\u7cfb\u7edf\uff0c\u4f7f\u516c\u53f8\u80fd\u591f\u5728\u751f\u4ea7\u8fc7\u7a0b\u4e2d\u8fdb\u884c\u66f4\u9891\u7e41\u7684\u6d4b\u8bd5\u3002Genevision \u7531\u4e13\u95e8\u4ece\u4e8b\u8d28\u91cf\u63a7\u5236\u7684 Warnex Inc. \u5f00\u53d1\u3002\uff08Wattnet Meatnews\uff09\u9876\u90e8<br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n2004 \u5e74\u52a8\u7269\u5065\u5eb7\u548c\u8425\u517b\u6982\u89c8<br \/>\n\u201c\u60a8\u7684\u5ba2\u6237\uff0c\u73b0\u5728\u548c\u5c06\u6765\u201d<br \/>\n&nbsp;<br \/>\n&nbsp;\u2013 \u4f60\u7684\u5ba2\u6237\u6709\u4f55\u53d8\u5316\uff1f<br \/>\n&nbsp;\u2013 \u60a8\u7684\u7ec4\u7ec7\u662f\u5426\u5df2\u4e3a\u8fd9\u4e9b\u53d8\u5316\u505a\u597d\u51c6\u5907\uff1f<br \/>\n&nbsp;\u2013 \u52a8\u7269\u536b\u751f\u4eba\u5458\u7ba1\u7406\u65b9\u9762\u7684\u60c5\u51b5\u5982\u4f55\uff1f<br \/>\n&nbsp;\u2013 \u5ba2\u6237\u5982\u4f55\u770b\u5f85\u5206\u9500\u5546\uff1f <br \/>\n&nbsp;\u2013 \u9886\u5148\u7684\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u53d6\u5f97\u4e86\u54ea\u4e9b\u6210\u529f\uff0c\u53c8\u9762\u4e34\u54ea\u4e9b\u6311\u6218\uff1f<br \/>\n&nbsp;\u2013 2003 \u5e74\u81f3 2004 \u5e74\u7684\u5e02\u573a\u8d8b\u52bf\u548c\u6d3b\u52a8<br \/>\n&nbsp;\u2013 2004 \u5e74 Brakke \u884c\u4e1a\u5c55\u671b<br \/>\n&nbsp;<br \/>\n\u6240\u6709\u8fd9\u4e9b\u95ee\u9898\u90fd\u5c06\u5728\u6211\u4eec\u5b89\u6392\u7684\u7814\u8ba8\u4f1a\u4e0a\u8fdb\u884c\u8ba8\u8bba\u548c\u89e3\u7b54\u3002\u6982\u8ff0\u4e5f\u53ef\u4ee5\u5355\u72ec\u4e3a\u8d35\u516c\u53f8\u7684\u7ba1\u7406\u56e2\u961f\u5b89\u6392\u3002\u6211\u4eec\u4fdd\u8bc1\uff0c\u6f14\u793a\u5c06\u5177\u6709\u6311\u6218\u6027\uff0c\u5e76\u5c06\u4fc3\u4f7f\u60a8\u91cd\u65b0\u8003\u8651\u60a8\u7684\u5546\u4e1a\u8ba1\u5212\u3002&nbsp; <br \/>\n&nbsp;<br \/>\n\u6982\u8ff0\u5c06\u4e8e 2 \u6708 16 \u65e5\u661f\u671f\u4e00\u5728\u62c9\u65af\u7ef4\u52a0\u65af\u7684\u897f\u90e8\u517d\u533b\u5927\u4f1a\u4e0a\u53d1\u5e03\u3002\u5ea7\u4f4d\u6709\u9650\uff0c\u8bf7\u7acb\u5373\u9884\u8ba2\u3002<br \/>\n&nbsp;<br \/>\n\u5982\u9700\u4e86\u89e3\u66f4\u591a\u8be6\u60c5\u6216\u9884\u8ba2\u5ea7\u4f4d\uff0c\u8bf7\u81f4\u7535 Jane Morgan\uff0c\u7535\u8bdd\uff1a972-243-4033\uff0c\u6216\u53d1\u9001\u7535\u5b50\u90ae\u4ef6\u81f3 <a href=\"mailto:jmorgan@brakkeconsulting.com\">jmorgan@brakkeconsulting.com<\/a>\u6216\u5728\u7ebf\u6ce8\u518c <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>\u3002   \u9876\u90e8<br \/>\n&nbsp;<br \/>\n******************************************************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u8d8a\u5357 \u8d8a\u5357\u5df2\u4e0b\u4ee4\u5c60\u5bb0 12 \u4e2a\u79bd\u6d41\u611f\u75ab\u60c5\u5730\u533a\u7684\u6240\u6709\u9e21\u53ea\u3002\u79bd\u6d41\u611f\u75ab\u60c5\u5df2\u5bfc\u81f4 13 \u4eba\u6b7b\u4ea1\uff0c\u5e76\u5f15\u53d1\u4e86\u4e9a\u6d32\u8303\u56f4\u5185\u7684\u5065\u5eb7\u6050\u614c\u3002\u8d8a\u5357\u5176\u4ed6 18 \u4e2a\u5730\u533a\u4e5f\u62a5\u544a\u4e86 H5N1 \u79bd\u6d41\u611f\u75ab\u60c5\uff0c\u4f46\u5230\u76ee\u524d\u4e3a\u6b62\uff0c\u653f\u5e9c\u5c1a\u672a\u4e0b\u4ee4\u5927\u89c4\u6a21\u5c60\u5bb0\u8fd9\u4e9b\u5730\u533a\u7684\u5bb6\u79bd\u3002\uff08Meating Place\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u6ce2\u5170 \u636e\u7f8e\u56fd\u8089\u7c7b\u534f\u4f1a\u79f0\uff0c\u6ce2\u5170\u5df2\u89e3\u9664\u5bf9\u90e8\u5206\u7f8e\u56fd\u725b\u8089\u7684\u8fdb\u53e3\u7981\u4ee4\u3002\u8fd9\u662f\u81ea 2003 \u5e74 12 \u6708 23 \u65e5\u534e\u76db\u987f\u5dde\u53d1\u73b0\u4e00\u5934\u611f\u67d3\u75af\u725b\u75c5\u7684\u5976\u725b\u4ee5\u6765\uff0c\u7b2c\u4e00\u4e2a\u89e3\u9664\u725b\u8089\u8fdb\u53e3\u7981\u4ee4\u7684\u56fd\u5bb6\u3002\u81ea\u53d1\u73b0\u75af\u725b\u75c5\u4ee5\u6765\uff0c\u5df2\u6709\u4e09\u5341\u591a\u4e2a\u56fd\u5bb6\u7981\u6b62\u7f8e\u56fd\u725b\u8089\u51fa\u53e3\u3002\u6ce2\u5170\u6bcf\u5e74\u4ec5\u8fdb\u53e3\u5c11\u91cf\u7f8e\u56fd\u725b\u8089\u3002\u7136\u800c\uff0c\u6ce2\u5170\u7684\u51b3\u5b9a\u53ef\u80fd\u4f1a\u9f13\u52b1\u5176\u4ed6\u56fd\u5bb6\u653e\u677e\u6216\u89e3\u9664\u7981\u4ee4\u3002\uff08Wattnet Meatnews\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u73af\u7403\u6d1e\u5bdf\u516c\u53f8\u5ba3\u5e03\uff0c\u6839\u636e\u5176\u519c\u4e1a\u96c6\u56e2\u7684\u4f30\u8ba1\uff0c\u6700\u8fd1\u7f8e\u56fd\u5976\u725b\u611f\u67d3\u75af\u725b\u75c5\u7684\u603b\u4f53\u5f71\u54cd\u5c06\u5bfc\u81f4 2003 \u5e74\u51c0\u519c\u573a\u6536\u5165\u4e0b\u964d 10%\u30022004 \u5e74 12 \u6708 23 \u65e5\uff0c\u534e\u76db\u987f\u5dde\u8bc1\u5b9e\u53d1\u73b0\u4e00\u5934\u611f\u67d3\u75af\u725b\u75c5\u7684\u8377\u65af\u5766\u5976\u725b\uff0c\u8fd9\u8fc5\u901f\u6539\u53d8\u4e86\u65e9\u5148\u5bf9 2004 \u5e74\u51c0\u519c\u573a\u6536\u5165\u6301\u5e73\u6216\u9002\u5ea6\u4e0b\u964d\u7684\u9884\u6d4b\uff0c\u4f7f\u5176\u53d8\u4e3a\u66f4\u8d1f\u9762\u7684\u9884\u6d4b\u30022004 \u5e74\u9884\u8ba1\u7684\u51c0\u519c\u573a\u6536\u5165\u4e0b\u964d\u4e3b\u8981\u662f\u7531\u4e8e\u5176\u5bf9\u725b\u4ef7\u548c\u725b\u8089\u51fa\u53e3\u7684\u5f71\u54cd\u3002\u5728\u53d1\u73b0\u75af\u725b\u75c5\u4e4b\u524d\uff0c\u9884\u8ba1 2004 \u5e74\u51fa\u53e3\u5c06\u589e\u957f 0.5%\uff0c\u8fbe\u5230 26.1 \u4ebf\u78c5\u3002\u7136\u800c\uff0c\u7531\u4e8e\u75af\u725b\u75c5\uff0c\u8fd9\u4e00\u51fa\u53e3\u9884\u6d4b\u88ab\u524a\u51cf\u81f3 6.3 \u4ebf\u78c5\uff0c\u6bd4 2003 \u5e74\u7684\u6c34\u5e73\u5927\u5e45\u4e0b\u964d 75%\u3002\u5982\u679c\u4e3b\u8981\u5e02\u573a\u957f\u671f\u5bf9\u7f8e\u56fd\u725b\u8089\u5173\u95ed\uff0c\u60c5\u51b5\u53ef\u80fd\u4f1a\u66f4\u7cdf\u3002\uff08\u7f8e\u901a\u793e\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u8054\u90a6\u519c\u4e1a\u5b98\u5458\u5ba3\u5e03\uff0c\u4ed6\u4eec\u53c8\u4ece\u534e\u76db\u987f\u5dde\u5c60\u5bb0\u7684\u52a0\u62ff\u5927\u725b\u7fa4\u4e2d\u627e\u5230\u4e86 9 \u5934\uff0c\u5176\u4e2d\u5305\u62ec\u53d7\u611f\u67d3\u7684\u8377\u65af\u5766\u725b\u3002\u8fd9\u4e00\u53d1\u73b0\u4f7f 2001 \u5e74\u8fdb\u5165\u7f8e\u56fd\u7684 81 \u5934\u52a0\u62ff\u5927\u725b\u4e2d\u627e\u5230\u4e86 23 \u5934\u3002\u540c\u6837\u5728\u534e\u76db\u987f\uff0cFDA \u8868\u793a\uff0c\u81ea\u4e0a\u4e2a\u6708\u53d1\u73b0\u75af\u725b\u75c5\u4ee5\u6765\uff0c\u5df2\u5728\u516d\u5bb6\u52a0\u62ff\u5927\u52a8\u7269\u9972\u6599\u516c\u53f8\u7684\u9972\u6599\u4e2d\u53d1\u73b0\u4e86\u8fdd\u7981\u52a8\u7269\u7ec4\u7ec7\u3002\u8fd9\u4e00\u53d1\u73b0\u610f\u4e49\u91cd\u5927\uff0c\u56e0\u4e3a\u5b83\u53ef\u80fd\u6709\u52a9\u4e8e\u8c03\u67e5\u4eba\u5458\u8ffd\u8e2a\u611f\u67d3\u6e90\u3002\uff08\u7f8e\u8054\u793e\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u4e0a\u5468\uff0c\u7f8e\u56fd\u3001\u52a0\u62ff\u5927\u548c\u58a8\u897f\u54e5\u7684\u519c\u4e1a\u90e8\u9ad8\u7ea7\u5b98\u5458\u4e3e\u884c\u4f1a\u8bae\uff0c\u8ba8\u8bba\u5317\u7f8e\u7684\u75af\u725b\u75c5\u95ee\u9898\uff0c\u4f46\u672a\u80fd\u5c31\u91cd\u65b0\u5f00\u653e\u725b\u8089\u4ea7\u54c1\u548c\u6d3b\u725b\u8fb9\u5883\u8fbe\u6210\u534f\u8bae\u3002\u7f8e\u56fd\u4e00\u76f4\u5728\u6566\u4fc3\u58a8\u897f\u54e5\uff08\u7f8e\u56fd\u725b\u8089\u7684\u4e3b\u8981\u5e02\u573a\uff09\u89e3\u9664\u5bf9\u7f8e\u56fd\u725b\u8089\u548c\u6d3b\u725b\u7684\u5168\u9762\u7981\u4ee4\u3002\u4e0a\u4e2a\u6708\uff0c\u79d1\u5b66\u5bb6\u5728\u534e\u76db\u987f\u8bca\u65ad\u51fa\u4e00\u5934\u8377\u65af\u5766\u725b\u611f\u67d3\u75af\u725b\u75c5\u540e\uff0c\u58a8\u897f\u54e5\u5bf9\u7f8e\u56fd\u725b\u8089\u548c\u6d3b\u725b\u5b9e\u65bd\u4e86\u5168\u9762\u7981\u4ee4\u3002\u52a0\u62ff\u5927\u5e0c\u671b\u7f8e\u56fd\uff08\u5176\u6700\u5927\u7684\u725b\u548c\u725b\u8089\u8d38\u6613\u4f19\u4f34\uff09\u548c\u58a8\u897f\u54e5\u89e3\u9664\u81ea 5 \u6708\u4efd\u52a0\u62ff\u5927\u75af\u725b\u75c5\u75c5\u4f8b\u4ee5\u6765\u5b9e\u65bd\u7684\u9650\u5236\u3002\u76ee\u524d\uff0c\u7f8e\u56fd\u5df2\u63a8\u8fdf\u5141\u8bb8\u52a0\u62ff\u5927\u5c06\u5e7c\u725b\u8fd0\u8fc7\u8fb9\u5883\uff0c\u56e0\u4e3a\u5e7c\u725b\u7684\u6f5c\u4f0f\u671f\u8f83\u957f\uff0c\u56e0\u6b64\u4e0d\u592a\u53ef\u80fd\u611f\u67d3\u75af\u725b\u75c5\u3002\uff08\u7f8e\u8054\u793e\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u65e5\u672c \u65e5\u672c\u653f\u5e9c\u5df2\u4e0b\u4ee4\u5bf9\u6240\u6709\u4ece\u7f8e\u56fd\u8fdb\u53e3\u5230\u65e5\u672c\u7684\u6d3b\u725b\u8fdb\u884c\u75af\u725b\u75c5\u68c0\u6d4b\u3002\u5317\u6d77\u9053\u53bf\u7684\u521d\u6b65\u68c0\u6d4b\u663e\u793a\uff0c\u4ece\u7f8e\u56fd\u8fdb\u53e3\u7684 403 \u5934\u6d3b\u725b\u6ca1\u6709\u51fa\u73b0\u75af\u725b\u75c5\u8ff9\u8c61\u3002\u5b83\u4eec\u662f\u8fc7\u53bb 15 \u5e74\u95f4\u4ece\u7f8e\u56fd\u8fdb\u53e3\u7684 2,059 \u5934\u6d3b\u725b\u4e4b\u4e00\u3002\uff08Wattnet Meatnews\uff09<br \/>\n&nbsp;<br \/>\n&gt;\u7f8e\u56fd \u636e\u5408\u4f17\u56fd\u9645\u793e\u62a5\u9053\uff0c2003\u5e74\u524d\u4e03\u4e2a\u6708\uff0c\u7f8e\u56fd\u519c\u4e1a\u90e8\u5b98\u5458\u6ca1\u6709\u5728\u534e\u76db\u987f\u5dde\u5bf9\u4efb\u4f55\u5546\u4e1a\u725b\u8fdb\u884c\u75af\u725b\u75c5\u68c0\u6d4b\u3002\u7f8e\u56fd\u519c\u4e1a\u90e8\u7684\u8bb0\u5f55\u663e\u793a\uff0c2001\u5e74\u81f32003\u5e74\u95f4\uff0c\u5171\u670935,000\u5934\u52a8\u7269\u63a5\u53d7\u4e86\u75af\u725b\u75c5\u7b5b\u67e5\u3002\u6b64\u5916\uff0c\u4e0a\u4e2a\u6708\u53d1\u73b0\u7f8e\u56fd\u9996\u4f8b\u75af\u725b\u75c5\u75c5\u4f8b\u7684 Vern&#039;s Moses Lake Meats \u5c60\u5bb0\u573a\u5728\u8fc7\u53bb\u4e24\u5e74\u4e2d\u6ca1\u6709\u5bf9\u4efb\u4f55\u52a8\u7269\u8fdb\u884c\u8fc7\u68c0\u6d4b\u3002\u636e\u5408\u4f17\u56fd\u9645\u793e\u62a5\u9053\uff0c\u68c0\u6d4b\u8bb0\u5f55\u8fd8\u63ed\u793a\u4e86\u8be5\u673a\u6784\u7684\u56fd\u5bb6\u75af\u725b\u75c5\u76d1\u6d4b\u7cfb\u7edf\u7684\u5176\u4ed6\u4e00\u4e9b\u6f0f\u6d1e\uff0c\u5305\u62ec\uff1a\uff081\uff09\u5728\u5df2\u77e5\u7684 700 \u5bb6\u5c60\u5bb0\u573a\u4e2d\uff0c\u53ea\u6709\u4e0d\u5230 100 \u5bb6\u8fdb\u884c\u4e86\u68c0\u6d4b\uff1b\uff082\uff09\u6765\u81ea\u56db\u5927\u725b\u8089\u751f\u4ea7\u5dde\u7684\u5976\u725b\u4ec5\u5360\u6240\u6709\u7b5b\u67e5\u52a8\u7269\u7684 11%\uff0c\u800c\u8fd9\u56db\u4e2a\u5dde\u7684\u5976\u725b\u6bcf\u5e74\u5c60\u5bb0\u7684\u725b\u53ea\u5360\u5168\u7f8e\u725b\u53ea\u7684\u8fd1 70%\uff1b \uff083\uff09\u5c3d\u7ba1\u5976\u725b\u88ab\u8ba4\u4e3a\u662f\u6700\u5bb9\u6613\u611f\u67d3\u75af\u725b\u75c5\u7684\u52a8\u7269\uff0c\u4f46\u4e00\u4e9b\u9876\u7ea7\u5976\u725b\u5c60\u5bb0\u573a\u53ea\u8fdb\u884c\u4e86\u51e0\u6b21\u62bd\u6837\uff0c\u751a\u81f3\u6839\u672c\u6ca1\u6709\u8fdb\u884c\u62bd\u6837\u3002\uff08Meating Place\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u5168\u7403\u98df\u54c1\u95ee\u9898\u4e2d\u5fc3 (CGFI) \u5ba3\u5e03\u63a8\u51fa\u201c\u75af\u725b\u75c5\u771f\u76f8\u201d\u7f51\u7ad9\uff0c <a href=\"http:\/\/www.mad-cow-facts.com\">www.mad-cow-facts.com<\/a>\u3002\u6700\u8fd1\u7684\u7814\u7a76\u8868\u660e\uff0c\u5728\u7f51\u4e0a\u5e76\u4e0d\u603b\u662f\u80fd\u8f7b\u6613\u627e\u5230\u6709\u5173\u725b\u6d77\u7ef5\u72b6\u8111\u75c5 (BSE) \u7684\u4e8b\u5b9e\u548c\u53ef\u9760\u4fe1\u606f\u3002\u8bb8\u591a\u6709\u673a\u98df\u54c1\u516c\u53f8\u3001\u5021\u5bfc\u7ec4\u7ec7\u548c\u7279\u6b8a\u5229\u76ca\u96c6\u56e2\u6b63\u8bd5\u56fe\u5229\u7528\u8bef\u5bfc\u6027\u7f51\u7ad9\u3001\u65b0\u95fb\u7a3f\u3001\u8d5e\u52a9\u94fe\u63a5\u548c\u6a2a\u5e45\u5e7f\u544a\u6765\u64cd\u7eb5\u4e92\u8054\u7f51\u641c\u7d22\u5f15\u64ce\u548c\u65b0\u95fb\u95e8\u6237\u7f51\u7ad9\u3002Mad-Cow-Facts.com \u81f4\u529b\u4e8e\u6d88\u9664\u8fd9\u79cd\u6df7\u4e71\uff0c\u5e76\u5e2e\u52a9\u6d88\u8d39\u8005\u627e\u5230\u6709\u5173 BSE \u7684\u53ef\u9760\u4fe1\u606f\u548c\u8bc4\u8bba\u3002\uff08PRNewswire\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u4e00\u7bc7\u65b0\u7684\u540c\u884c\u8bc4\u8bae\u6587\u7ae0\u8868\u660e\uff0c\u7981\u6b62\u5728\u98df\u7528\u52a8\u7269\u4e2d\u4f7f\u7528\u6297\u751f\u7d20\u53ef\u80fd\u4f1a\u635f\u5bb3\u4eba\u7c7b\u548c\u52a8\u7269\u7684\u5065\u5eb7\u3002\u672c\u6708\u53d1\u8868\u5728\u300a\u6297\u83cc\u5316\u5b66\u7597\u6cd5\u6742\u5fd7\u300b\u4e0a\u7684\u8fd9\u4efd\u62a5\u544a\u53d1\u73b0\uff0c\u51e0\u4e4e\u6ca1\u6709\u79d1\u5b66\u8bc1\u636e\u8868\u660e\u5728\u98df\u7528\u52a8\u7269\u4e2d\u4f7f\u7528\u6297\u751f\u7d20\u4f1a\u5bf9\u4eba\u7c7b\u5065\u5eb7\u4ea7\u751f\u8d1f\u9762\u5f71\u54cd\u3002\u6765\u81ea\u6b27\u6d32\u548c\u7f8e\u56fd\u7684\u76d1\u6d4b\u6570\u636e\u663e\u793a\uff0c\u52a8\u7269\u548c\u4eba\u7c7b\u7684\u8010\u836f\u7ec6\u83cc\u6a21\u5f0f\u5b58\u5728\u8bb8\u591a\u8131\u8282\uff0c\u56e0\u6b64\u4e0d\u592a\u53ef\u80fd\u901a\u8fc7\u98df\u54c1\u4f9b\u5e94\u5e7f\u6cdb\u4f20\u64ad\u8010\u836f\u7ec6\u83cc\u3002\u6b64\u5916\uff0c\u867d\u7136\u6b27\u6d32\u7981\u6b62\u4f7f\u7528\u6297\u751f\u7d20\u4fc3\u8fdb\u751f\u957f\u5e76\u6ca1\u6709\u964d\u4f4e\u6b27\u6d32\u4eba\u7c7b\u7684\u6297\u751f\u7d20\u8010\u836f\u6c34\u5e73\uff0c\u4f46\u7f8e\u56fd\u6570\u636e\u663e\u793a\uff0c\u6297\u751f\u7d20\u8010\u836f\u6027\u98df\u6e90\u6027\u75c5\u539f\u4f53\u7684\u53d1\u751f\u7387\u603b\u4f53\u5448\u4e0b\u964d\u8d8b\u52bf\uff0c\u98df\u6e90\u6027\u7ec6\u83cc\u5f15\u8d77\u7684\u75c5\u4f8b\u6570\u91cf\u4e5f\u5728\u4e0b\u964d\u3002\u7f8e\u56fd\u52a8\u7269\u5065\u5eb7\u7814\u7a76\u6240\u7684\u72ec\u7acb\u987e\u95ee\u59d4\u5458\u4f1a\u5236\u5b9a\u4e86\u8fd9\u4efd\u62a5\u544a\uff1b\u8be5\u59d4\u5458\u4f1a\u7531\u4e00\u7fa4\u4eba\u7c7b\u5fae\u751f\u7269\u5b66\u5bb6\u3001\u98ce\u9669\u8bc4\u4f30\u5458\u3001\u517d\u533b\u548c\u52a8\u7269\u5065\u5eb7\u4e13\u5bb6\u7ec4\u6210\u3002\uff08Drover&#039;s\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd\u54e5\u4f26\u6bd4\u4e9a\u5e7f\u64ad\u516c\u53f8\u62d2\u7edd\u4e86 PETA \u51c6\u5907\u7684\u8d85\u7ea7\u7897\u5e7f\u544a\u3002\u8be5\u5e7f\u544a\u58f0\u79f0\u5403\u8089\u4f1a\u5bfc\u81f4\u9633\u75ff\uff0c\u5e76\u7528\u4e24\u540d\u6f02\u4eae\u5973\u6027\u548c\u4e00\u540d\u4e0d\u5e78\u7684\u62ab\u8428\u9001\u8d27\u5458\u6765\u8868\u8fbe\u5176\u89c2\u70b9\u3002\u201c\u6211\u4eec\u4e0d\u63a5\u53d7\u5bf9\u6709\u4e89\u8bae\u7684\u516c\u5171\u95ee\u9898\u504f\u8892\u4efb\u4f55\u4e00\u65b9\u7684\u5e7f\u544a\uff0c\u90e8\u5206\u539f\u56e0\u662f\u6211\u4eec\u8ba4\u4e3a\u8fa9\u8bba\u4e0d\u5e94\u8be5\u7531\u6709\u94b1\u4eba\u63a7\u5236\uff0c\u201d\u54e5\u4f26\u6bd4\u4e9a\u5e7f\u64ad\u516c\u53f8\u7684\u6267\u884c\u526f\u603b\u88c1\u8bf4\u3002PETA \u7684\u53d1\u8a00\u4eba\u8868\u793a\uff0c\u54e5\u4f26\u6bd4\u4e9a\u5e7f\u64ad\u516c\u53f8\u7684\u653f\u7b56\u524d\u540e\u77db\u76fe\uff0c\u56e0\u4e3a\u5979\u5728\u8fc7\u53bb\u7684\u8d85\u7ea7\u7897\u8f6c\u64ad\u4e2d\u770b\u5230\u8fc7\u8c34\u8d23\u5438\u70df\u548c\u9189\u9152\u9a7e\u9a76\u7684\u5e7f\u544a\u3002\uff08Drover&#039;s Alert\uff09<br \/>\n&nbsp;<br \/>\n********************************************************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<br \/>\n&nbsp;<br \/>\n\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0c\u5f88\u9ad8\u5174\u5728\u5965\u5170\u591a\u89c1\u5230\u4f60\u4eec\u8fd9\u4e48\u591a\u4eba\u3002\u5317\u7f8e\u517d\u533b\u5927\u4f1a\u6bcf\u5e74\u90fd\u5728\u8fdb\u6b65\uff0c\u5df2\u6210\u4e3a\u52a8\u7269\u4fdd\u5065\u884c\u4e1a\u771f\u6b63\u7279\u522b\u7684\u8d38\u6613\u5c55\u3002Colin Burrows \u535a\u58eb\u548c NAVC \u5de5\u4f5c\u4eba\u5458\u5bf9\u4eca\u5e74\u7684\u4f1a\u8bae\u8bc4\u5206\u4e3a A+\u3002<br \/>\n&nbsp;<br \/>\n\u6211\u4eec\u8fd8\u8981\u611f\u8c22\u53c2\u52a0\u6211\u4eec\u4e24\u6b21\u6982\u89c8\u4f1a\u8bae\u7684 70 \u591a\u4f4d\u884c\u4e1a\u7ecf\u7406\u3002\u611f\u8c22\u5927\u5bb6\u5bf9\u6211\u4eec 2004 \u5e74\u6982\u89c8\u7684\u79ef\u6781\u8bc4\u4ef7\u3002\u6709\u5173\u60a8\u7684\u5ba2\u6237\u53ca\u5176\u5bf9\u60a8 2004 \u5e74\u53ca\u4ee5\u540e\u4e1a\u52a1\u7684\u5f71\u54cd\u7684\u65b0\u6982\u89c8\u4fe1\u606f\u4f3c\u4e4e\u7279\u522b\u4ee4\u4eba\u611f\u5174\u8da3\u3002<br \/>\n&nbsp;<br \/>\n\u6211\u4eec\u671f\u5f85\u4e0b\u5468\u5728\u4e9a\u7279\u5170\u5927\u56fd\u9645\u5bb6\u79bd\u535a\u89c8\u4f1a\u548c\u83f2\u5c3c\u514b\u65af\u5168\u56fd\u725b\u8089\u534f\u4f1a\u4f1a\u8bae\u4e0a\u89c1\u5230\u5927\u5bb6\u3002<br \/>\n&nbsp;<br \/>\n\u795d\u5468\u672b\u6109\u5feb\u3002<br \/>\n&nbsp;<br \/>\n\u7f57\u6069\u00b7\u5e03\u62c9\u514b<br \/>\n******************************************************************* <br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u4e3a Brakke \u7684\u552f\u4e00\u8d22\u4ea7<br \/>\n\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf<br \/>\n\u5e76\u6070\u5f53\u5730\u5f52\u529f\u4e8e Brakke Consulting, Inc.<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u7684\u66f4\u591a\u4fe1\u606f<br \/>\n\u548c\u8054\u5408\u7814\u7a76\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9<br \/>\n<a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n2735 Villa Creek\uff0c\u5957\u623f 140<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>\n<p>\u4e3a\u4e86\u63a5\u6536 HTML \u7248\u672c\u800c\u4e0d\u662f\u6587\u672c <br \/>\n\u5982\u9700\u67e5\u770b\u672c\u65b0\u95fb\u7a3f\u7684\u7248\u672c\uff0c\u8bf7\u4f7f\u7528\u672c\u65b0\u95fb\u7a3f\u5e95\u90e8\u7684\u94fe\u63a5<br \/>\n\u672c\u5468\u7684\u65f6\u4e8b\u901a\u8baf\u4e2d\u5199\u9053\uff1a\u201c\u5982\u679c\u4f60\u5e0c\u671b\u6211\u4eec<br \/>\n\u5c06\u60a8\u7684\u59d3\u540d\u4ece\u901a\u544a\u540d\u5355\u4e2d\u5220\u9664\uff0c\u6216\u8005\u5982\u679c\u60a8\u9700\u8981<br \/>\n\u66f4\u6539\u60a8\u7684\u4e2a\u4eba\u8d44\u6599\u6216\u7535\u5b50\u90ae\u4ef6\u5730\u5740\uff0c\u8bf7\u70b9\u51fb\u6b64\u5904\u201d\u3002<br \/>\n\u7136\u540e\u70b9\u51fb\u4f60\u7535\u5b50\u90ae\u4ef6\u5730\u5740\u4e0b\u65b9\u7684\u6309\u94ae<br \/>\nHTML\uff0c\u7136\u540e\u70b9\u51fb\u201c\u66f4\u65b0\u8ba2\u9605\u201d\u3002<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c ************************************************************************ Brakke Consulting 2004\u5e741\u670823\u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u53ca\u8bc4\u8bba \u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. ************************************************************************ \u60a8\u73b0\u5728\u53ef\u4ee5\u4f7f\u7528\u6b64\u90e8\u5206\u76f4\u63a5\u8df3\u8f6c\u5230\u7279\u5b9a\u516c\u53f8\u7684\u65b0\u95fb\u3002\u53ea\u9700\u70b9\u51fb\u516c\u53f8\u540d\u79f0\u5373\u53ef\u3002\u7acb\u5373\u6ce8\u518c\uff0c\u9884\u8ba2 2004 \u5e74 2 \u6708\u897f\u90e8\u517d\u533b\u5b66\u5927\u4f1a\u6982\u89c8\u7684\u5ea7\u4f4d \u8df3\u8f6c\u81f3\uff1a \u6536\u76ca\uff1a Fort Dodge Novartis Pfizer Virbac SA \u5176\u4ed6\u65b0\u95fb\uff1a Abbott Labs Boehringer Ingelheim Enfer Scientific eMerge Interactive Farnam Heska Intervet Luitpold Merial Novartis PetMed Express PharmaGap Plumrose USA Virbac Corp. ******************************************************************** \u516c\u53f8\u6536\u76ca\u62a5\u544a &gt; \u8f89\u745e\u5ba3\u5e03\u4e86\u5176\u52a8\u7269\u4fdd\u5065\u90e8\u95e8 2003 \u5e74\u7b2c\u56db\u5b63\u5ea6\u548c\u5e74\u7ec8\u7684\u4e1a\u7ee9\u3002\u5e74\u7ec8\u6536\u5165\u4e3a $15.98 \u4ebf\u7f8e\u5143\uff0c\u6bd4 2002 \u5e74\u589e\u52a0 43%\uff0c\u8fd9\u53cd\u6620\u4e86 2003 \u5e74\u6536\u8d2d Pharmacia \u7684\u5f71\u54cd\u3002\u7b2c\u56db\u5b63\u5ea6\u6536\u5165\u4e3a $5.08 \u4ebf\u7f8e\u5143\uff0c\u589e\u52a0 57%\u3002\u7b2c\u56db\u5b63\u5ea6\u7684\u4e1a\u7ee9\u53cd\u6620\u4e86 Pharmacia \u4ea7\u54c1\u7ec4\u5408\u7684\u589e\u52a0\uff0c\u5e76\u53d7\u5230\u4f34\u4fa3\u52a8\u7269\u4ea7\u54c1 Rimadyl\u3001Revolution \u548c Clavamox\/Synulox \u4ee5\u53ca\u725b\u751f\u7269\u5236\u54c1\u7684\u5f3a\u52b2\u8868\u73b0\u4ee5\u53ca\u6709\u5229\u7684\u8d27\u5e01\u6c47\u7387\u7684\u63a8\u52a8\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09\u9876\u90e8 &gt; \u8bfa\u534e\u516c\u53f8\u516c\u5e03\u4e86 2003 \u5e74\u7b2c\u56db\u5b63\u5ea6\u548c\u5e74\u672b\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u7684\u4e1a\u7ee9\u3002\u5168\u5e74\u9500\u552e\u989d\u4e3a $6.82 \u4ebf\uff0c\u6bd4 2002 \u5e74\u589e\u957f 9%\uff0c\u5f97\u76ca\u4e8e<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/20031\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-20031","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/20031\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for January 23, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company.&nbsp; Simply click on the company name. &nbsp; Sign up now to reserve your seat for the 2004 Overview at the Western Veterinary Conference in February &nbsp; JUMP TO: &nbsp; earnings: Fort Dodge Novartis Pfizer Virbac SA &nbsp; &nbsp; other news: Abbott Labs Boehringer Ingelheim Enfer Scientific eMerge Interactive Farnam Heska Intervet Luitpold Merial Novartis PetMed Express PharmaGap Plumrose USA Virbac Corp. &nbsp; ******************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Pfizer announced results for its Animal Health division for the 4th quarter and year-end 2003.&nbsp; Year-end revenues were $1,598 million, a 43% increase over 2002, which reflects the 2003 acquisition of Pharmacia.&nbsp; Fourth-quarter revenues were $508 million, an increase of 57%.&nbsp; Fourth quarter results reflect the addition of the Pharmacia product portfolio, and were driven by strong performances by the companion animal products Rimadyl, Revolution and Clavamox\/Synulox, and cattle biologicals, and by favorable currency exchange rates.&nbsp; (company website)&nbsp; top &nbsp; &gt;&nbsp; Novartis reported results for its Animal Health division for the 4th quarter and year-end 2003. Full-year sales of $682 million, an increase of 9% compared to 2002, were driven by double-digit growth inView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/20031\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2004-01-23T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-11T10:56:31+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for January 23, 2004\",\"datePublished\":\"2004-01-23T18:51:17+00:00\",\"dateModified\":\"2018-04-11T10:56:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/\"},\"wordCount\":2998,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\"},\"datePublished\":\"2004-01-23T18:51:17+00:00\",\"dateModified\":\"2018-04-11T10:56:31+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/ja\/20031\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/20031\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/ja\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for January 23, 2004\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/ja\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/20031\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for January 23, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company.&nbsp; Simply click on the company name. &nbsp; Sign up now to reserve your seat for the 2004 Overview at the Western Veterinary Conference in February &nbsp; JUMP TO: &nbsp; earnings: Fort Dodge Novartis Pfizer Virbac SA &nbsp; &nbsp; other news: Abbott Labs Boehringer Ingelheim Enfer Scientific eMerge Interactive Farnam Heska Intervet Luitpold Merial Novartis PetMed Express PharmaGap Plumrose USA Virbac Corp. &nbsp; ******************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Pfizer announced results for its Animal Health division for the 4th quarter and year-end 2003.&nbsp; Year-end revenues were $1,598 million, a 43% increase over 2002, which reflects the 2003 acquisition of Pharmacia.&nbsp; Fourth-quarter revenues were $508 million, an increase of 57%.&nbsp; Fourth quarter results reflect the addition of the Pharmacia product portfolio, and were driven by strong performances by the companion animal products Rimadyl, Revolution and Clavamox\/Synulox, and cattle biologicals, and by favorable currency exchange rates.&nbsp; (company website)&nbsp; top &nbsp; &gt;&nbsp; Novartis reported results for its Animal Health division for the 4th quarter and year-end 2003. Full-year sales of $682 million, an increase of 9% compared to 2002, were driven by double-digit growth inView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/20031\/","og_site_name":"Brakke Consulting Website","article_published_time":"2004-01-23T18:51:17+00:00","article_modified_time":"2018-04-11T10:56:31+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"15 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for January 23, 2004","datePublished":"2004-01-23T18:51:17+00:00","dateModified":"2018-04-11T10:56:31+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/"},"wordCount":2998,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/","url":"https:\/\/brakkeconsulting.com\/ja\/20031\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#website"},"datePublished":"2004-01-23T18:51:17+00:00","dateModified":"2018-04-11T10:56:31+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/ja\/20031\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/ja\/20031\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/ja\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for January 23, 2004"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/ja\/#website","url":"https:\/\/brakkeconsulting.com\/ja\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/ja\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/ja\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=20031"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20031\/revisions"}],"predecessor-version":[{"id":20164,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/20031\/revisions\/20164"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=20031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=20031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=20031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}